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OBJECTIVES We sought to determine whether sauna therapy, a thermal vasodilation therapy, improves
endothelial function in patients with coronary risk factors such as hypercholesterolemia,
hypertension, diabetes mellitus and smoking.
BACKGROUND Exposure to heat is widely used as a traditional therapy in many different cultures. We have
recently found that repeated sauna therapy improves endothelial and cardiac function in
patients with chronic heart failure.
METHODS Twenty-five men with at least one coronary risk factor (risk group: 38 6 7 years) and 10
healthy men without coronary risk factors (control group: 35 6 8 years) were enrolled.
Patients in the risk group were treated with a 60°C far infrared-ray dry sauna bath for 15 min
and then kept in a bed covered with blankets for 30 min once a day for two weeks. To assess
endothelial function, brachial artery diameter was measured at rest, during reactive hyperemia
(flow-mediated endothelium-dependent dilation [%FMD]), again at rest and after sublingual
nitroglycerin administration (endothelium-independent vasodilation [%NTG]) using high-
resolution ultrasound.
RESULTS The %FMD was significantly impaired in the risk group compared with the control group
(4.0 6 1.7% vs. 8.2 6 2.7%, p , 0.0001), while %NTG was similar (18.7 6 4.2% vs. 20.4 6
5.1%). Two weeks of sauna therapy significantly improved %FMD in the risk group (4.0 6
1.7% to 5.8 6 1.3%, p , 0.001). In contrast, %NTG did not change after two weeks of sauna
therapy (18.7 6 4.2% to 18.1 6 4.1%).
CONCLUSIONS Repeated sauna treatment improves impaired vascular endothelial function in the setting of
coronary risk factors, suggesting a therapeutic role for sauna treatment in patients with risk
factors for atherosclerosis. (J Am Coll Cardiol 2001;38:1083–8) © 2001 by the American
College of Cardiology
Endothelial dysfunction is observed in patients with con-
ventional coronary risk factors such as hyperlipidemia (1),
hypertension (2), diabetes mellitus (3) and cigarette smok-
ing (4–6). Endothelial dysfunction is believed to represent
an early stage of atherosclerosis. It has been reported that
chronic inhibition of nitric oxide (NO) production acceler-
ates neointima formation and impairs endothelial function
in hypercholesterolemic rabbits (7). Endothelial function of
the brachial artery has been shown to be related to the
intima-media thickness of the carotid artery (8). Further-
more, coronary endothelial dysfunction is associated with
increased cardiac events and poor prognosis (9,10). Modi-
fication of coronary risk factors through the use of
cholesterol-lowering therapy (11–17), antihypertensive
therapy (18–21), antioxidant therapy (22–25), L-arginine
supplementation (26–29) and estrogen replacement therapy
in postmenopausal women (30,31) improves impaired en-
dothelial function in the coronary or brachial arteries.
Exposure to heat is widely used as a traditional therapy in
many cultures. However, its precise mechanisms remain
unclear. We have previously reported that repeated use of a
sauna at 60°C improves hemodynamics and clinical symp-
toms in patients with chronic heart failure (32,33). In
addition, we have recently found that repeated sauna ther-
apy improves endothelial function and decreases plasma
brain natriuretic peptide concentrations in patients with
chronic heart failure (34).
Therefore, we hypothesized that repeated sauna therapy
can improve impaired endothelial function in the setting of
conventional coronary risk factors. The purpose of this study
was to determine whether repeated sauna therapy improves
impaired endothelial function in patients with coronary risk
factors.
METHODS
Study population. The study population was comprised of
25 men with at least one coronary risk factor (risk group,
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mean age: 38 6 7 years, range: 25 to 51 years) and 10
healthy men without coronary risk factors (control group,
mean age: 35 6 8 years, range: 21 to 47 years). None of the
patients had coronary artery disease or was taking medica-
tions. Written informed consent was obtained from all of
the individuals, and the protocol was approved by the Ethics
Committee of the Faculty of Medicine, Kagoshima Univer-
sity.
Laboratory examination. Fasting blood was obtained in
the morning before and after two weeks of sauna therapy for
the measurement of biochemical parameters. Plasma con-
centrations of thiobarbituric acid reactive substances
(TBARS) were measured using the thiobarbituric acid
reaction method.
Definition of conventional coronary risk factors. Hyper-
tension was defined as a supine systolic blood pressure (BP)
$140 mm Hg or a diastolic BP $90 mm Hg measured by
a mercury sphygmomanometer after 15 min of rest on two
separate occasions. Hypercholesterolemia was defined as a
fasting blood total cholesterol $220 mg/dl. Diabetes mel-
litus was defined as a fasting plasma glucose concentration
$126 mg/dl. Obesity was defined as a body mass index
$26.4. Smokers were defined as individuals who smoked
$20 cigarettes per day at the time of the study.
Sauna therapy. A far infrared-ray dry sauna system (Olym-
pia Co., Miyazaki, Japan) was used for sauna therapy.
Patients underwent sauna therapy at 60°C for 15 min and
then were kept supine in a bed outside the sauna for 30 min
with sufficient warmth provided by blankets (32). Sauna
therapy was performed in the risk group once a day for two
weeks. The patients maintained their other daily habits.
Vascular function. To assess vascular function, we used a
noninvasive technique described by Celermajer et al. (35).
Briefly, a high-resolution Doppler ultrasound system (HDI-
5000; ATL, Bothel, Washington) equipped with a 12-
MHz linear-array transducer was used to measure the
diameter and flow velocity of the left brachial artery.
Individuals rested in a supine position for 15 min before the
first scan and were kept supine throughout the study. The
left brachial artery was scanned in both long- and short-axis
views to obtain the maximum dimension. We confirmed the
center of the artery when the clearest images of the anterior
and posterior walls of the artery were obtained, as described
previously (1). After the confirmation, we scanned in
longitudinal section throughout the study. The first resting
image was recorded, and arterial flow velocity was measured
using a pulsed Doppler signal directed 60° to the longitu-
dinal axis of the artery. After measuring the BP of the right
upper limb, a cuff was inflated around the left forearm to a
pressure of 20 mm Hg above the systolic BP for 5 min.
During inflation, we confirmed that no blood flow was
present downstream of the cuff with photoplethysmography
monitoring (FCP-4731, IB-70, Fukuda Denshi, Kum-
amoto, Japan) of the second finger of the left hand. The
second scan was recorded continuously for 30 s before and
3 min after rapid cuff deflation. Fifteen minutes later, a
repeat resting scan was performed. Sublingual nitroglycerin
(NTG) spray (300 mg; Myocol Spray, Toa Eiyo Co.,
Tokyo, Japan) was then administered, and the last scan was
recorded 3 to 5 min later. All images were recorded on
S-VHS videotape using an MD830 videocassette recorder
(SONY, Tokyo, Japan).
The arterial diameter was measured between the intima-
blood interfaces on the anterior and posterior walls with
ultrasonic calipers (Fig. 1) during the onset of the R-wave of
the electrocardiogram for five consecutive cardiac cycles,
and the five measurements were then averaged. These
measurements were performed by two blinded observers.
Percent flow-mediated dilation (%FMD) is expressed as the
maximum percent change in diameter 45 to 60 s after rapid
cuff release normalized to the first resting scan
(endothelium-dependent vasodilation). The maximum di-
lation after NTG administration is also expressed as the
percent change normalized to the repeat resting scan
([%NTG] endothelium-independent vasodilation). Blood
flow was calculated by multiplying the velocity-time integral
of the Doppler flow signal by the heart rate and cross-
sectional area of the brachial artery. Reactive hyperemia is
defined as the maximum flow during the first 15 s after cuff
release divided by the baseline flow. Vascular function was
evaluated once in the control group and twice in the risk
group (before the first sauna treatment and the day after the
last sauna treatment).
Interobserver variability was determined by calculating
the mean and standard deviation for the difference in the
measurements made by the two observers for 20 arterial
studies. The interobserver variability for %FMD was 0.2 6
1.1%.
Abbreviations and Acronyms
BP 5 blood pressure
eNOS 5 endothelial isoform of nitric oxide synthase
NO 5 nitric oxide
NTG 5 nitroglycerin
TBARS 5 thiobarbituric acid reactive substances
%FMD 5 percent flow-mediated dilation
%NTG 5 percent nitroglycerin-induced dilation
Figure 1. Representative example of ultrasound images of brachial artery at
rest (left) and 60 s after cuff release (right). The diameter of the artery
increased from 3.22 mm (rest) to 3.48 mm (after cuff release) in response
to increased blood flow. In this case, the percentage of flow-mediated
dilation was 8.1%.
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In preliminary studies in eight patients with coronary risk
factors, we confirmed that the %FMD did not change at
two-week interval without any modification of coronary risk
factors (4.6 6 2.5% vs. 4.7 6 1.8%, p 5 NS). After this
confirmation, we started this study.
Statistical analysis. Measurements are expressed as the
mean 6 SD. A two-sided paired Student t test was used to
compare changes in vascular responses and laboratory values
before and after sauna therapy. A value of p , 0.05 was
considered statistically significant.
RESULTS
Clinical characteristics. The clinical characteristics of
both groups are summarized in Table 1. In the risk group,
8 patients had hypertension; 3 patients had diabetes melli-
tus; 8 patients had hypercholesterolemia, and 15 patients
were current smokers (Table 1).
Effects of sauna therapy on body weight, heart rate and
BP. The body weight decreased significantly (75.2 6
9.9 kg to 74.9 6 9.9 kg, p , 0.05), while the heart rate did
not change (68 6 10 beats/min to 68 6 10 beats/min, p 5
NS) after two weeks of sauna therapy. Both systolic and
diastolic BP decreased significantly (systolic BP: 128 6
18 mm Hg to 124 6 17 mm Hg, p , 0.01; diastolic BP:
77 6 17 mm Hg to 72 6 16 mm Hg, p , 0.05) after two
weeks of sauna therapy (Table 2).
Effects of sauna therapy on biochemical parameters.
After two weeks of sauna therapy, liver and renal function
did not change. The hematocrit and serum total cholesterol,
triglyceride, high-density lipoprotein cholesterol and uric
acid concentrations did not change significantly. In contrast,
the fasting plasma glucose concentration decreased signifi-
cantly (99 6 25 mg/dl to 94 6 16 mg/dl, p , 0.05). The
plasma TBARS concentration did not change (2.8 6 0.6
Table 1. Clinical Characteristics of the Control and Risk Groups
Control
Group
(n 5 10)
Risk
Group
(n 5 25)
p
Value
Age (yrs) 35 6 8 38 6 7 0.25
Hypercholesterolemia (%) 0/10 8/25 (32)
Total cholesterol (mg/dl) 187 6 12 214 6 44 0.07
Hypertension (%) 0/10 8/25 (32)
SBP (mm Hg) 122 6 11 128 6 18 0.34
DBP (mm Hg) 76 6 8 77 6 17 0.90
Diabetes mellitus (%) 0/10 3/25 (12)
Fasting plasma glucose (mg/dl) 91 6 7 99 6 25 0.29
Smoking (%) 0/10 15/25 (60)
Obesity (%) 0/10 9/25 (36)
BMI 23.2 6 1.8 25.6 6 2.8 0.02
Resting arterial diameter (mm) 3.6 6 0.4 3.9 6 0.3 0.09
%FMD (%) 8.2 6 2.7 4.0 6 1.7 ,0.0001
%NTG (%) 20.4 6 5.1 18.7 6 4.2 0.32
Values are expressed as the mean 6 SD.
BMI 5 body mass index; DBP 5 diastolic blood pressure; SBP 5 systolic blood pressure; %FMD 5 percentage of
flow-mediated dilation; %NTG 5 percentage of nitroglycerin-induced dilation.
Table 2. Changes in Clinical Parameters After Two Weeks of Sauna Treatment
Before
Sauna
After
Two Weeks
of Sauna
p
Value
Body weight (kg) 75.2 6 9.9 74.9 6 9.9 ,0.05
Heart rate (beats/min) 68 6 10 68 6 10 NS
Systolic blood pressure (mm Hg) 128 6 18 124 6 17 ,0.01
Diastolic blood pressure (mm Hg) 77 6 17 72 6 16 ,0.05
Hematocrit (%) 47.6 6 2.9 47.2 6 2.3 NS
Total cholesterol (mg/dl) 214 6 44 208 6 34 NS
Triglyceride (mg/ml) 268 6 327 221 6 159 NS
HDL cholesterol (mg/dl) 51 6 11 50 6 11 NS
Uric acid (mg/dl) 6.8 6 1.8 6.6 6 1.5 NS
Fasting plasma glucose (mg/dl) 99 6 25 94 6 16 ,0.05
TBARS (nmol/ml) 2.8 6 0.6 2.9 6 0.6 NS
Resting arterial diameter (mm) 3.9 6 0.3 3.9 6 0.3 NS
Reactive hyperemia (%) 398 6 170 352 6 215 NS
%FMD (%) 4.0 6 1.7 5.8 6 1.3 ,0.001
%NTG (%) 18.7 6 4.2 18.1 6 4.1 NS
Values are expressed as the mean 6 SD.
HDL cholesterol 5 high-density lipoprotein cholesterol; TBARS 5 thiobarbituric acid reactive substances; %FMD 5
percentage of flow-mediated dilation; %NTG 5 percentage of nitroglycerin-induced dilation.
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nmol/ml to 2.9 6 0.6 nmol/ml, p 5 NS) after two weeks of
sauna therapy (Table 2).
Effects of sauna therapy on vascular function. No patient
had any significant arterial stenosis or plaques in the brachial
artery studied. In the control group, the mean resting
arterial diameter was 3.6 6 0.4 mm, and the %FMD
(endothelium-dependent vasodilation) and the %NTG
(endothelium-independent vasodilation) were 8.2 6 2.7%
and 20.4 6 5.1%, respectively. In the risk group, the mean
resting arterial diameter was larger, but not significantly
larger than that in the control group (3.9 6 0.3 mm vs.
3.6 6 0.4 mm, p 5 NS). The %FMD was significantly
lower than that in the control group (4.0 6 1.7% vs. 8.2 6
2.7%, p , 0.0001), but the %NTG was not different from
that in the control group (18.7 6 4.2% vs. 20.4 6 5.1%, p 5
NS) (Table 1). After two weeks of sauna therapy, the mean
resting arterial diameter in the risk group did not change
significantly (3.9 6 0.3 mm to 3.9 6 0.3 mm, p 5 NS). In
addition, reactive hyperemia also did not change (398 6
170% to 352 6 215%, p 5 NS). While the %FMD
increased significantly from the baseline value (4.0 6 1.7%
to 5.8 6 1.3%, p , 0.001; Table 2, Fig. 2), the %NTG did
not change (18.7 6 4.2% to 18.1 6 4.1%, p 5 NS) after two
weeks of sauna therapy (Table 2).
Effects of a single sauna therapy on blood flow of the
brachial artery. To assess the degree of blood flow increase
of the brachial artery after a single sauna therapy, we
measured blood flow at rest and during sauna therapy in
eight patients with coronary risk factors. Blood flow of the
brachial artery significantly increased by 68% after 15 min of
sauna therapy (188 6 36 ml/min to 313 6 55 ml/min, p ,
0.0001) and remained elevated by 51% 30 min after sauna
therapy (188 6 36 ml/min to 275 6 80 ml/min, p , 0.05)
(Fig. 3).
DISCUSSION
In this study we found that two weeks of sauna treatment
improves impaired endothelial function in patients with
conventional coronary risk factors, whereas the vascular
response to NTG does not change. This suggests that
long-term thermal therapy may play a preventive role in
atherosclerosis.
Possible mechanisms of endothelial dysfunction by cor-
onary risk factors. In the endothelium, the amino acid
L-arginine is converted to L-citrulline and NO by the
endothelial isoform (eNOS) of NO synthase. Nitric oxide is
an important vasodilator substance and helps prevent ath-
erosclerosis by maintaining vasodilation and inhibiting
platelet aggregation, leukocyte adhesion and proliferation of
smooth muscle cells in the arterial wall (36). Therefore, NO
plays an important role in endothelial function. We could
not determine the precise mechanism by which repeated
sauna treatment improves impaired endothelial function in
patients with conventional coronary risk factors. However,
three major mechanisms responsible for endothelial dys-
function induced by these risk factors have been proposed.
First, an alteration in the signaling pathway that activates
eNOS has been observed in the hypercholesterolemic con-
dition (37,38). Second, reduced expression of eNOS: re-
duced eNOS gene and protein expression have been re-
ported in cultured endothelial cells exposed to cigarette
smoke extract (39) and in endothelial cells from spontane-
ously hypertensive rats (40). Endothelial isoform of nitric
oxide synthase protein expression is also reduced in skeletal
muscle from streptozotocin-induced diabetic rats (41).
Third, reduced bioavailability of NO because of oxidative
stress: because free radicals can inactivate NO (42), oxida-
tive stress reduces the bioavailability of NO (43–48). More-
Figure 2. Changes in individual percentage of flow-mediated dilation
(%FMD) after two weeks of sauna therapy. *p , 0.001 vs. before sauna
therapy.
Figure 3. Changes in blood flow of the brachial artery during a single sauna
therapy in eight subjects with coronary risk factors. Blood flow significantly
increased by 68% after 15 min of sauna therapy and remained elevated by
51% 30 min after sauna therapy. *p , 0.0001 vs. before sauna therapy;
**p , 0.05 vs. before sauna therapy.
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over, it has been reported that increased oxidized low-
density lipoprotein concentrations decrease eNOS activity
by displacing eNOS from plasmalemmal caveolae (49). We
found that the TBARS concentration did not change after
two weeks of sauna treatment (Table 2), suggesting that
restoration of bioavailability of NO by decreasing oxidative
stress is not involved.
Potential role of shear stress in the improvement of
endothelial function. Shear stress is an important factor
that increases eNOS activity and stimulates eNOS expres-
sion (50–53). We have previously reported that a single
sauna treatment induces a 1.5-fold increase in cardiac
output in patients with chronic heart failure (32). In
addition, we observed that blood flow of the brachial artery
significantly increased by 68% during sauna therapy (Fig. 3).
This increased blood flow increases shear stress. We have
recently demonstrated that the gene expression and protein
level of eNOS increase significantly in peripheral arteries
from the golden hamster after four weeks of repeated sauna
therapy (54). Therefore, we believe that repeated sauna
therapy improves endothelial function by increasing eNOS
activity and upregulating eNOS expression by increasing
shear stress. The significant decrease in BP after two weeks
of sauna treatment (Table 2) is probably due to improved
endothelium-dependent vasodilation.
In an interesting parallel, exercise has also been demon-
strated to improve endothelial dysfunction in healthy older
men (55), in patients with chronic heart failure (56) and in
patients with the polymetabolic syndrome (57). It has been
reported that four weeks of cycle training for 30 min three
times per week significantly increases the basal release of
NO in healthy volunteers, and a 30-min cycling induces a
threefold increase in forearm blood flow and a 15% increase
in blood viscosity (58). They suggest that elevated shear
stress contributes to the increased basal release of NO.
These phenomena are similar to those induced by sauna
therapy in this study. Sauna therapy has an advantage in that
it is applicable to subjects who are unable to exercise.
Effects of sauna therapy on fasting plasma glucose con-
centration. A significant decrease in fasting plasma glucose
concentration after two weeks of sauna treatment (Table 2)
was observed, consistent with the previous report using
hot-tub therapy (59). Increased blood flow to skeletal
muscles is reported to increase glucose uptake (60); how-
ever, further studies will be needed to clarify the precise
mechanisms of long-term effects of the sauna therapy on
plasma glucose metabolism. Although all the subjects were
advised to make no changes in their lifestyle in this study,
significant reduction in BP and fasting plasma glucose
concentration was observed after two weeks of sauna treat-
ment. These changes were significant but modest and
within normal limits, so it is not likely that they contributed
to the improvement of endothelial function.
Study limitations. Because we evaluated the effects of
sauna treatment on endothelial function in a small number
of individuals with coronary risk factors, the importance of
each risk factor remains uncertain. Further studies in larger
numbers of individuals with conventional coronary risk
factors are needed.
Conclusions. Repeated thermal therapy improves im-
paired endothelial function in patients with coronary risk
factors, suggesting a preventive role for thermal therapy for
atherosclerosis.
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